Hepatoprotective effects of AdipoRon against d-galactosamine-induced liver injury in mice
Abstract
Adiponectin is an antidiabetic and antiatherogenic adipokine, which plays distinct roles in the balance of energy homoeostasis. As an insulin sensitizing hormone, adiponectin exerts multiple biological effects by the specific receptors (AdipoR1 and AdipoR2), through activation of AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR)α pathways. AdipoRon, an orally active synthetic small-molecule AdipoR agonist, shows very similar effects to adiponectin in vitro and in vivo, which could be a promising therapeutic approach for obesity-related disorders. In view of the regulatory effects of adiponectin or AdipoRon on inflammatory response and energy metabolism, they might be endowed a curative potential for tissue damage. Hence, its effects and possible mechanism were investigated. In vitro studies on hepatocytes (L02) and macrophages (RAW264.7) suggested a protective and anti-inflammatory potential of AdipoRon. The effects were verified in acute hepatic injury mice induced by d-galactosamine (D-GalN): hepatic lesions were restored by AdipoRon or bicyclol (positive reference drug) pretreatment, which were characterized by a significant increase in serological and hepatic biomarkers (AST, ALT, MDA and NOSs). Besides, AdipoRon attenuated the inflammation in the liver, characterized by the dwindling proinflammatory macrophage infiltration, as well as the shrinkage of tumor necrosis factor-α (TNF-α), transforming growth factor beta 1 (TGF-β1), interleukin-1 beta (IL-1β) and interleukin-6 (IL-6); meanwhile conversely promoted AMPK activation by phosphorylation. Combined with liver histopathology, these results demonstrated the hepatoprotective effects of AdipoRon against D-GalN-induced damage, which might be ascribed to the attenuation of inflammation, inhibition of free radical reactions, as well as enhancement of liver energy metabolism.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AdipoRon has been proposed for treatment of type 2 diabetes and other obesity-related disorders in mice.
“AdipoRon has first been proposed for the treatment of type 2 diabetes and other obesity-related disorders in mice [32,106,107,108,137,138].”
From Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together? (2020) · cites this paper as [137]
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104 · see citing works
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · see citing works
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · see citing works
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625 · see citing works
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602 · see citing works
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · see citing works
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238 · see citing works
Points of control in inflammation
Nathan, C. (2002) · Nature · doi:10.1038/nature01320 · Cited by 2,738 · see citing works
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,275 · see citing works
Hawley, S. A., Davison, M., Woods, A., Davies, S. P., Beri, R. K., Carling, D., & Hardie, D. G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27879 · Cited by 1,264 · see citing works
M1 and M2 Macrophages: Oracles of Health and Disease
Mills, C. D. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,145 · see citing works
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133 · see citing works
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
Jeon, S.-M., Chandel, N. S., & Hay, N. (2012) · Nature · doi:10.1038/nature11066 · Cited by 1,132 · see citing works
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952 · see citing works
Beyond insulin resistance in NASH: TNF-α or adiponectin?
Hui, J. M., Hodge, A., Farrell, G. C., Kench, J. G., Kriketos, A., & George, J. (2004) · Hepatology · doi:10.1002/hep.20280 · Cited by 942 · see citing works
Adiponectin as an anti-inflammatory factor
Ouchi, N., & Walsh, K. X. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.026 · Cited by 883 · see citing works
Salminen, A., Hyttinen, J. M. T., & Kaarniranta, K. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0748-0 · Cited by 866 · see citing works
Immune response to biologic scaffold materials
Badylak, S. F., & Gilbert, T. W. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2007.11.003 · Cited by 857 · see citing works
Adipokines and Insulin Resistance
Rabe, K., Lehrke, M., Parhofer, K. G., & Broedl, U. C. (2008) · Molecular Medicine · doi:10.2119/2008-00058.rabe · Cited by 814 · see citing works
Adiponectin acts in the brain to decrease body weight
Qi, Y., Takahashi, N., Hileman, S. M., Patel, H. R., Berg, A. H., Pajvani, U. B., Scherer, P. E., & Ahima, R. S. (2004) · Nature Medicine · doi:10.1038/nm1029 · Cited by 809 · see citing works
Sağ, D., Carling, D., Stout, R. D., & Suttles, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8633 · Cited by 798 · see citing works
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · see citing works
AMPK: a key regulator of energy balance in the single cell and the whole organism
Hardie, D. G. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.116 · Cited by 709 · see citing works
Kadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D. R., Graham, L., Parker, C. E., Nyska, A., Wachsman, J. T., Ames, B. N., Basu, S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.017 · Cited by 699 · see citing works
Macrophages and Inflammatory Mediators in Tissue Injury
Laskin, D. L., & Pendino, K. J. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003255 · Cited by 618 · see citing works
Combs, T. P., Pajvani, U. B., Berg, A. H., Lin, Y., Jelicks, L. A., Laplante, M., Nawrocki, A. R., Rajala, M. W., Parlow, A. F., Cheeseboro, L., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1068 · Cited by 545 · see citing works
Experimental hepatitis induced by d-galactosamine
KEPPLER, D. O. R., Lesch, R., Reutter, W. G., & Decker, K. (1968) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(68)90042-7 · Cited by 520 · see citing works
Dzeja, P. P., & Terzic, A. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10041729 · Cited by 482 · see citing works
Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms
Ricklin, D., & Lambris, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203487 · Cited by 480 · see citing works
Decker, K., & KEPPLER, D. O. R. (2005) · Springer eBooks · doi:10.1007/bfb0027661 · Cited by 446 · see citing works
AMP-activated protein kinase: new regulation, new roles?
Carling, D., Thornton, C., Woods, A., & Sanders, M. J. (2012) · Biochemical Journal · doi:10.1042/bj20120546 · Cited by 375 · see citing works
Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation
Bungard, D., Fuerth, B. J., Zeng, P.-Y., Faubert, B., Maas, N. L., Viollet, B., Carling, D., Thompson, C. B., Jones, R. G., & Berger, S. L. (2010) · Science · doi:10.1126/science.1191241 · Cited by 372 · see citing works
Bradham, C. A., Plümpe, J., Manns, M. P., Brenner, D. A., & Trautwein, C. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.3.g387 · Cited by 355 · see citing works
Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S., Kuroda, T., Hori, M., Kawase, I., & Hirota, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9554-9575.2005 · Cited by 351 · see citing works
Hyperglycemia-Induced Apoptosis in Human Umbilical Vein Endothelial Cells
Ido, Y., Carling, D., & Ruderman, N. B. (2002) · Diabetes · doi:10.2337/diabetes.51.1.159 · Cited by 323 · see citing works
Zhao, X., Zmijewski, J. W., Lorne, E., Liu, G., Park, Y.-J., Tsuruta, Y., & Abraham, E. H. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90210.2008 · Cited by 300 · see citing works
The Trapping of Uridine Phosphates by d ‐Galactosamine, d ‐Glucosamine, and 2‐Deoxy‐ d ‐galactose
KEPPLER, D. O. R., Rudigier, J., Bischoff, E., & Decker, K. (1970) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1970.tb01160.x · Cited by 297 · see citing works
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in bioscience · doi:10.2741/3460 · Cited by 281 · see citing works
Dissection of the multiple mechanisms of TNF‐α‐induced apoptosis in liver injury
Ding, W., & Yin, X. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00469.x · Cited by 277 · see citing works
Adiponectin, a key adipokine in obesity related liver diseases.
Buechler, C., Wanninger, J., & Neumeier, M. (2011) · PubMed Central · doi:10.3748/wjg.v17.i23.2801 · Cited by 261 · see citing works
Cacicedo, J. M., Yagihashi, N., Keaney, J. F., Ruderman, N. B., & Ido, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.177 · Cited by 233 · see citing works
Xu, X. J., Gauthier, M., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M. G., Valentine, R. J., & Ruderman, N. B. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p022905 · Cited by 229 · see citing works
Galactosamine induced liver injury.
Decker, K., & KEPPLER, D. O. R. (1972) · PubMed · Cited by 217 · see citing works
Macrophage polarization in the maculae of age‐related macular degeneration: A pilot study
Cao, X., Shen, D., Patel, M. M., Tuo, J., Johnson, T. M., Olsen, T. W., & Chan, C. (2011) · Pathology International · doi:10.1111/j.1440-1827.2011.02695.x · Cited by 211 · see citing works
Mechanisms of endotoxin shock and endotoxin hypersensitivity
Galanos, C., & Freudenberg, M. A. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80349-9 · Cited by 196 · see citing works
Chan, G. C. T., Bivins-Smith, E. R., Smith, M. S., Smith, P. M., & Yurochko, A. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.698 · Cited by 188 · see citing works
Clemens, M. G. (1999) · Hepatology · doi:10.1002/hep.510300148 · Cited by 188 · see citing works
Osakabe, N., Yasuda, A., Natsume, M., Sanbongi, C., Kato, Y., Osawa, T., & Yoshikawa, T. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00970-x · Cited by 187 · see citing works
Wu, S., & Wei, Y. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.09.014 · Cited by 182 · see citing works
Bai, A., Ma, A. G., Yong, M., Weiss, C. R., Ma, Y., Guan, Q., Bernstein, C. N., & Peng, Z. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.009 · Cited by 181 · see citing works
Adiponectin, a key adipokine in obesity related liver diseases
Christa, Buechler, Josef, Wanninger, Markus, M. L., & Neumeier (2011) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 167 · see citing works
Role of Nitric Oxide in Liver Injury
Chen, T., Zamora, R., Zuckerbraun, B. S., & Billiar, T. R. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479582 · Cited by 158 · see citing works
Hishinuma, I., Nagakawa, J., Hirota, K., Miyamoto, K., Tsukidate, K., Yamanaka, T., Katayama, K., & Yamatsu, I. (1990) · Hepatology · doi:10.1002/hep.1840120518 · Cited by 154 · see citing works
Steinberg, G. R. (2007) · Cell Cycle · doi:10.4161/cc.6.8.4135 · Cited by 147 · see citing works
Nath, N., Giri, S., Prasad, R. C., Salem, M. L., Singh, A. K., & Singh, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.566 · Cited by 136 · see citing works
García-Villafranca, J., Guillén, A., & Castro, J. (2008) · Biochimie · doi:10.1016/j.biochi.2007.09.019 · Cited by 130 · see citing works
Zhao, X., Xue, C., Li, Z., Cai, Y.-P., Liu, H., & Qi, H. (2004) · Journal of Applied Phycology · doi:10.1023/b:japh.0000044822.10744.59 · Cited by 116 · see citing works
She, C., Zhu, L., Zhen, Y.-F., Wang, X., & Dong, Q. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.046 · Cited by 116 · see citing works
Shi, Y., Sun, J., He, H., Guo, H., & Zhang, S. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.02.023 · Cited by 107 · see citing works
Activation of AMPK inhibits inflammation in MRL/lpr mouse mesangial cells
Peairs, A., Radjavi, A., Davis, S., Li, L., Ahmed, A. A., Giri, S., & Reilly, C. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03924.x · Cited by 106 · see citing works
Role of adiponectin in metabolic and cardiovascular disease
Lee, S., & Kwak, H. (2014) · Journal of Exercise Rehabilitation · doi:10.12965/jer.140100 · Cited by 105 · see citing works
Mukherjee, P., Mulrooney, T. J., Marsh, J., Blair, D., Chiles, T. C., & Seyfried, T. N. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-37 · Cited by 101 · see citing works
Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice
Wolf, A. M., Wolf, D. G. F., Avila, M. A., Moschen, A. R., Berasain, C., Enrich, B., Rumpold, H. F., & Tilg, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.08.019 · Cited by 100 · see citing works
Carling, D., & Viollet, B. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.005 · Cited by 89 · see citing works
Wang, H., & Li, Y. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.080 · Cited by 86 · see citing works
Markiewski, M. M., DeAngelis, R. A., & Lambris, J. D. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.019 · Cited by 86 · see citing works
Adiponectin deficiency exacerbates lipopolysaccharide/D-galactosamine-induced liver injury in mice
Matsumoto, H. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i21.3352 · Cited by 74 · see citing works
TGF-β1 and IFN-γ Direct Macrophage Activation by TNF-α to Osteoclastic or Cytocidal Phenotype
Fox, S. W., Fuller, K., Bayley, K. E., Lean, J. M., & Chambers, T. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.4957 · Cited by 68 · see citing works
Mechanism of protective action of bicyclol against CCl 4 ‐induced liver injury in mice
Liu, G.-T., Li, Y., Wei, H. L., Zhang, H., Xu, J. Y., & Yu, L. H. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01103.x · Cited by 63 · see citing works
Pelletier, A., & Coderre, L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00186.2006 · Cited by 58 · see citing works
Hu, H., & Chen, R.-D. (1992) · Biological Trace Element Research · doi:10.1007/bf02783894 · Cited by 56 · see citing works
Immunolpathology of Acute Galactosamine Hepatitis in Rats
Jonker, A. M., Dijkhuis, F. W. J., Kroese, F. G. M., Hardonk, M. J., & Grond, J. (1990) · Hepatology · doi:10.1002/hep.1840110415 · Cited by 48 · see citing works
MacDonald, J. R., Beckstead, J. H., & Smuckler, E. A. (1987) · PubMed · Cited by 33 · see citing works
Mechanisms and mediators in hepatic necrosis
Decker, K. (1993) · Gastroenterologia Japonica · doi:10.1007/bf02782883 · Cited by 22 · see citing works
Wang, Y., Zhang, M., Wang, C., Ye, B., & Hua, Z. (2013) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2013.09.010 · Cited by 13 · see citing works
Prevention of Galactosamine-Induced Hepatotoxicity in Rats with Fructose-1,6-Diphosphate
Markov, A. K., Farias, L. A., Bennett, W. S., Subramony, C., & Mihas, A. A. (2008) · Pharmacology · doi:10.1159/000138861 · Cited by 13 · see citing works
Wang, Y., Chen, B., Ke, Y., Wang, C., & Ye, B. (2014) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2014.07.031 · Cited by 6 · see citing works
Flagged first, then by citations
1 of the 79 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Zhang, H. Y., Wang, H. L., Zhong, G. Y., & Zhu, J. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1517185 · Cited by 74 · see citing works
Abou-Samra, M., Selvais, C. M., Dubuisson, N., & Brichard, S. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072620 · Cited by 72 · see citing works
Liu, Y., Vu, V., & Sweeney, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00842 · Cited by 69 · see citing works
Zhong, J., Gong, W., Chen, J., Qing, Y., Shu-yue, W., Li, H., Huang, C., Chen, Y., Wang, Y., Xu, Z.-Z., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.036 · Cited by 66 · see citing works
Potential Adiponectin Receptor Response Modifier Therapeutics
Otvos, L. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00539 · Cited by 60 · see citing works
Zhuo, Y., Hua, L., Feng, B., Jiang, X., Li, J., Jiang, D., Huang, X., Yingguo, Z., Li, Z., Yan, L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.020 · Cited by 49 · see citing works
Targeting Adiponectin in Breast Cancer
Nehme, R., Diab‐Assaf, M., Decombat, C., Delort, L., & Caldefie‐Chezet, F. (2022) · Biomedicines · doi:10.3390/biomedicines10112958 · Cited by 46 · see citing works
Barbalho, S. M., Méndez‐Sánchez, N., & Laurindo, L. F. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115871 · Cited by 46 · see citing works
<scp>AdipoRon</scp>, a new therapeutic prospect for Duchenne muscular dystrophy
Abou‐Samra, M., Selvais, C. M., Boursereau, R., Lecompte, S., Noel, L., & Brichard, S. M. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12531 · Cited by 44 · see citing works
Zhou, Q., Xiang, H., Li, A., Wu, L., Huang, Z., Guo, J., Wang, P., Chi, Y., Xiang, K., Xu, Y., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5783 · Cited by 44 · see citing works
Therapeutic effects of AdipoRon on liver inflammation and fibrosis induced by CCl4 in mice
Sha, M., Gao, Y., Deng, C., Wan, Y., Zhuang, Y., Hu, X., & Wang, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106157 · Cited by 42 · see citing works
Miao, W., Jiang, L., Xu, F., Lyu, J., Jiang, X., He, M., Liu, Y., Yang, T., Leak, R. K., Stetler, R. A., et al. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102125 · Cited by 43 · see citing works
Ming, L., Qiao, X.-Y., Yi, L., Siren, D., He, J., Hai, L., Guo, F., Xiao, Y., & Ji, R. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17247 · Cited by 39 · see citing works
Zhang, J.-C., Wang, Z.-X., Huo, D., & Shao, Y.-Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01034 · Cited by 33 · see citing works
Selvais, C. M., de Carrizosa, M. A. D., Nachit, M., Versele, R., Dubuisson, N., Noël, L., Gillard, J., Leclercq, I. A., Brichard, S. M., & Abou‐Samra, M. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13148 · Cited by 33 · see citing works
Onodera, T., Zadeh, E. H. G., Xu, P. H., Gordillo, R., Guo, Z., Joffin, N., Yu, B., Scherer, P. E., & Li, W. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100095 · Cited by 26 · see citing works
Duan, Z., Tu, C., Liu, Q. H., Li, S., Li, Y., Xie, P., & Li, Z. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29605 · Cited by 23 · see citing works
Porphyran‐derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice
Wang, X., Liu, D., Wang, Z., Cai, C., Jiang, H., & Yu, G. (2021) · The FASEB Journal · doi:10.1096/fj.202000763rrr · Cited by 21 · see citing works
Camel milk ameliorates inflammatory mechanisms in an alcohol-induced liver injury mouse model
Ming, L., Qi, B., Hao, S., & Ji, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-02357-1 · Cited by 20 · see citing works
Chemical induction of hepatic apoptosis in rodents
Qinna, N. A., & Ghanim, B. Y. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3740 · Cited by 19 · see citing works
Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders
Francischetti, E. A., Dezonne, R. S., Pereira, C. M., Martins, C. J. D. M., Celoria, B. M. J., de Oliveira, P. A. C., & de Abreu, V. G. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1239-4349 · Cited by 19 · see citing works
Gamberi, T., Magherini, F., & Fiaschi, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071544 · Cited by 18 · see citing works
Uchida, T., Ueta, T., Honjo, M., & Aihara, M. (2019) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2018.0152 · Cited by 13 · see citing works
Screening for adiponectin receptor agonists and their metabolites in urine and dried blood spots
Dib, J., Tretzel, L., Piper, T., Lagojda, A., Kuehne, D., Schänzer, W., & Thevis, M. (2017) · Clinical mass spectrometry · doi:10.1016/j.clinms.2017.10.002 · Cited by 8 · see citing works
Yang, X., & Huang, Y. (2020) · Medicinal Chemistry Research · doi:10.1007/s00044-020-02608-2 · Cited by 5 · see citing works
Son, Y., Hwang, J., Choi, K., & Lee, J. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0714-x · Cited by 4 · see citing works
Adiponectin receptor agonist reduces broiler hepatic lipid deposition
Tan, W., Jiang, K., Zhang, Y., Gao, H., Tang, X., & Jiang, S. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1667501 · Cited by 2 · see citing works
Guo, Q., Lin, J., Shen, Y. L., Zheng, Y. J., Chen, X., Su, M., Zhang, J. C., Wang, J., Tang, H. J., Su, G., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112282 · Cited by 2 · see citing works
Pang, H., Han, Y., Shuang, S., Zheng, X., Li, L., Xia, G., Zhu, J., Han, J., & Zang, H. (2025) · Natural Product Communications · doi:10.1177/1934578x251349455 · Cited by 1 · see citing works
Potential Role of Adiponectin Receptor Agonist, AdipoRon in Cardiometabolic Disease
Cho, E., & Lee, S. (2019) · Exercise Science · doi:10.15857/ksep.2019.28.2.102 · Cited by 1 · see citing works
Adiponectin-Based Therapeutics for Cancer Treatment
Li, D., Cao, H., Chen, J., Liu, M. R., & Wang, Y. (2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084817117040007 · Cited by 1 · see citing works
Adiponectin in cigarette smoke–induced epithelial-mesenchymal transition
Panico, F., Spaziano, G., Nigro, E., Mirra, D., Esposito, R., Caiazzo, E., Daniele, A., & D’Agostino, B. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.105004
- Authors
- Wang, Y., Wan, Y., Ye, G., Wang, P., Xue, X., Wu, G., & Ye, B.
- Affiliations
- China Pharmaceutical University (CN)
- Nanjing Normal University (CN)
- Corresponding author
- Ye, Boping
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 93
- Pages
- 123-131
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2517176431
- Cited by
- 34
- References
- 79
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 3
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmaceutical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Science and Technology Major Projects for Key New Drugs Innovation (2012ZX09103301-018)
- National Natural Science Foundation of China (30572280, 30801454)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- AdipoRon, adiponectin, hepatoprotection, D-galactosamine-induced liver injury, acute liver injury, liver inflammation, AMPK, macrophage infiltration, TNF-α, oxidative stress, liver energy metabolism, bicyclol
- MeSH terms
- Animals, Cell Line, Transformed, Galactosamine, Humans, Liver, Male, Mice, Inbred C57BL, Piperidines, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review